These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4136228)

  • 1. Enhancement of amphetamine action after interruption of ascending serotonergic pathways.
    Green TK; Harvey JA
    J Pharmacol Exp Ther; 1974 Jul; 190(1):109-17. PubMed ID: 4136228
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of d-amphetamine and apomorphine upon operant behavior and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens.
    Robbins TW; Roberts DC; Koob GF
    J Pharmacol Exp Ther; 1983 Mar; 224(3):662-73. PubMed ID: 6402587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased fixed-ratio performance and differential d- and l-amphetamine action following norepinephrine depletion by intraventricular 6-hydroxydopamine.
    Peterson DW; Sparber SB
    J Pharmacol Exp Ther; 1974 Dec; 191(3):349-57. PubMed ID: 4427285
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of d-amphetamine, chlorpromazine, and chlordiazepoxide on intercurrent behavior during spaced-responding schedules.
    Smith JB; Clark FC
    J Exp Anal Behav; 1975 Sep; 24(2):241-8. PubMed ID: 1206333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of amphetamine on electroshock responses in developing rats.
    Vernadakis A; Robb D
    Dev Psychobiol; 1974 Jan; 7(1):89-95. PubMed ID: 4812273
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of inhibition of monoamine uptake by cocaine, methylphenidate and amphetamine.
    Taylor D; Ho BT
    Res Commun Chem Pathol Pharmacol; 1978 Jul; 21(1):67-75. PubMed ID: 684280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased self-administration of d-amphetamine after destruction of 5-hydroxytryptaminergic neurons.
    Lyness WH; Friedle NM; Moore KE
    Pharmacol Biochem Behav; 1980 Jun; 12(6):937-41. PubMed ID: 7403208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of D-amphetamine on the behaviour of rats in the open field apparatus: interaction with four neuroleptics and changes in biogenic amine metabolsm in discrete brain regions.
    Lynch MA; Kenny M; Leonard BE
    Ir J Med Sci; 1978 Oct; 147(10):337-50. PubMed ID: 711421
    [No Abstract]   [Full Text] [Related]  

  • 9. Behavioral effects of L-5-hydroxytryptophan after destruction of ascending serotonergic pathways in the rat: the role of catecholaminergic neurons.
    Yunger LM; Harvey JA
    J Pharmacol Exp Ther; 1976 Feb; 196(2):307-15. PubMed ID: 1255478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral depression and its neurochemical correlates at high doses of d-amphetamine in rats.
    Copeland RL; Aulakh CS; Bhattacharyya AK; Pradhan SN
    Neuropharmacology; 1980 Oct; 19(10):1027-30. PubMed ID: 7191484
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of four amphetamines on brain biogenic amines and their metabolites.
    Leonard BE
    Biochem Pharmacol; 1972 May; 21(9):1289-97. PubMed ID: 5038674
    [No Abstract]   [Full Text] [Related]  

  • 12. An experimental analysis of behavioral factors in drug dependence.
    Thompson T; Pickens R
    Fed Proc; 1975 Aug; 34(9):1759-70. PubMed ID: 1097265
    [No Abstract]   [Full Text] [Related]  

  • 13. Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies.
    Schechter LE; Bolaños FJ; Gozlan H; Lanfumey L; Haj-Dahmane S; Laporte AM; Fattaccini CM; Hamon M
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1335-47. PubMed ID: 1702155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropsychopharmacology of monoamines and their regulatory enzymes.
    Lipton MA
    Adv Biochem Psychopharmacol; 1974; 12(0):443-54. PubMed ID: 4153941
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of d-amphetamine on schedule-controlled key pressing and drinking in the chimpanzee.
    Byrd LD
    J Pharmacol Exp Ther; 1973 Jun; 185(3):633-41. PubMed ID: 4197278
    [No Abstract]   [Full Text] [Related]  

  • 16. A study of the central effects of 5,6-dihydroxytryptamine.
    Longo VG; Scotti de Carolis A; Liuzzi A; Massotti M
    Adv Biochem Psychopharmacol; 1974; 10():109-20. PubMed ID: 4546514
    [No Abstract]   [Full Text] [Related]  

  • 17. Enhanced locomotor activity following amphetamine in mouse-killing rats.
    Salama AI; Goldberg ME
    Arch Int Pharmacodyn Ther; 1973 Jul; 204(1):162-9. PubMed ID: 4795753
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of chlorpromazine on behavior maintained by a multiple schedule of reinforcement.
    Clark FC
    J Pharmacol Exp Ther; 1969 Apr; 166(2):179-88. PubMed ID: 5776979
    [No Abstract]   [Full Text] [Related]  

  • 19. Association between the behavioral and neurochemical effects of amphetamine: hemispheric asymmetry study.
    Lee EH; Huang SL; Chai CY
    Life Sci; 1987 Apr; 40(14):1431-7. PubMed ID: 2882400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that serotonin mediates some behavioral effects of amphetamine.
    Sloviter RS; Drust EG; Connor JD
    J Pharmacol Exp Ther; 1978 Aug; 206(2):348-52. PubMed ID: 308099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.